Monthly Archives: June 2025

AB Science provides an update on the renegotiation of loan repayment terms with its financial creditors

30/06/2025 – AB Science today announced that an agreement in principle has been reached with its financial creditors to postpone by 24 months the repayment of its bank debt

New peer-reviewed data provide strong evidence supporting masitinib potential for the treatment of Alzheimer’s disease

23/06/2025 – AB Science today announced that a new study from an independent research team based in China presents new evidences showing that masitinib offers a promising new approach to treating Alzheimer’s disease

AB Science announces issuance of a Canadian patent protecting the composition of matter of AB8939, including its use in the treatment of acute myeloid leukemia, with protection until 2036

12/06/2025 – AB Science today announced that the patent office of Canada has  granted a patent protecting the composition of matter of AB8939, and closely related compounds, until 2036

AB Science announces EMA approval of Masivet shelf-life extension to 4 years

09/06/2025 – AB Science today announced that the European Medicine Agency (EMA) has approved the extension of the shelf life of its veterinary medicine MASIVET® from 36 months to 48 months